《2004/24/欧盟指令》虽然具有规范传统植物药市场准入条件，保护人类安全的作用，但在客观上它还具有限制进口、保护本国同类商品生产者利益的作用。该指令既不符合GATT1994第3条规定的国民待遇原则，也不符合GATT1994 第20 条规定的“一般例外”原则。我国完全可以通过WTO争端解决机制迫使欧盟废除或修改《2004/24/欧盟指令》。

"DIRECTIVE 2004/24/EC" is a mandatory regulation issued by the European Parliament and the Council of the European Union, which regulates the conditions for the simplified registration and authorization to place a medicinal product on the EU market. This Article analyses the provisions concerning the conditions for application und its procedures and other important contents of "DIRECTIVE 2004/24/EC". Then it discusses the influences of this Directive on the internationalization and the industry of Chinese medicinal herbs.

上海市教委科研创新项目（12ZS034）:中医药国际科技合作中的利益分享机制研究，负责人：宋晓亭。